CompletedNCT00417794
Atomoxetine for attention problems in children exposed to alcohol before birth
About this title
Read the official source — NCT00417794Medication studyAges 4–11United StatesADHD
Understand this study
Who was this study for?
Listed age limits: 4 years to 11 years.
- Listed locations
- Oklahoma CitySee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateAugust 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 38
- Sponsor
- University of Oklahoma
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 4 Years to 11 Years
- Official registry ID
- NCT00417794
- Official title
Show the full official title
A Study of the Efficacy of Atomoxetine in Treating the Inattention, Impulsivity and Hyperactivity in Children With Fetal Alcohol Syndrome or Effects
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Oklahoma City
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Oklahoma, a university.
Did this study involve medication?
Yes. The study involved medication, including Strattera and Placebo.
Who was this study for?
Listed age limits: 4 years to 11 years.
